| Literature DB >> 29755344 |
Fazilath Uzma1, Chakrabhavi D Mohan2, Abeer Hashem3, Narasimha M Konappa4, Shobith Rangappa5, Praveen V Kamath1, Bhim P Singh6, Venkataramana Mudili7, Vijai K Gupta8, Chandra N Siddaiah4, Srinivas Chowdappa1, Abdulaziz A Alqarawi9, Elsayed F Abd Allah9.
Abstract
Cancer is a major cause of death worldwide, with an increasing number of cases being reported annually. The elevated rate of mortality necessitates a global challenge to explore newer sources of anticancer drugs. Recent advancements in cancer treatment involve the discovery and development of new and improved chemotherapeutics derived from natural or synthetic sources. Natural sources offer the potential of finding new structural classes with unique bioactivities for cancer therapy. Endophytic fungi represent a rich source of bioactive metabolites that can be manipulated to produce desirable novel analogs for chemotherapy. This review offers a current and integrative account of clinically used anticancer drugs such as taxol, podophyllotoxin, camptothecin, and vinca alkaloids in terms of their mechanism of action, isolation from endophytic fungi and their characterization, yield obtained, and fungal strain improvement strategies. It also covers recent literature on endophytic fungal metabolites from terrestrial, mangrove, and marine sources as potential anticancer agents and emphasizes the findings for cytotoxic bioactive compounds tested against specific cancer cell lines.Entities:
Keywords: anticancer agents; bioactive metabolites; camptothecin; fungal alkaloids; natural compounds; podophyllotoxin; taxol; vinca alkaloids
Year: 2018 PMID: 29755344 PMCID: PMC5932204 DOI: 10.3389/fphar.2018.00309
Source DB: PubMed Journal: Front Pharmacol ISSN: 1663-9812 Impact factor: 5.810
List of taxol-producing endophytic fungi and their host plants.
| 1 | 0.024–0.05 | Stierle et al., | ||
| 2 | 60–70 | Strobel et al., | ||
| 3 | 0.014–1.487 | Li, | ||
| 4 | 0.127–0.485 | Strobel et al., | ||
| 5 | 0.030–0.831 | Li, | ||
| 6 | – | Wang et al., | ||
| 7 | 51.06–125.7 | Zhou et al., | ||
| 8 | 10.25 | Hu et al., | ||
| 9 | 161.24 | Hu et al., | ||
| 10 | 225.2 | Xu et al., | ||
| 11 | 4–18 | Guo et al., | ||
| 12 | 280.5 | Venkatachalam et al., | ||
| 13 | 113.3 | Gangadevi et al., | ||
| 14 | 163.4 | Gangadevi and Muthumary, | ||
| 15 | 187.6 | Gangadevi and Muthumary, | ||
| 16 | 137–265 | Kumaran et al., | ||
| 17 | 125–235 | Senthil Kumaran et al., | ||
| 18 | 274 | Kumaran et al., | ||
| 19 | 1.6 | Chakravarthi et al., | ||
| 20 | 131 | Li et al., | ||
| 21 | 163.35 | Deng et al., | ||
| 22 | 560 | Sun et al., | ||
| 23 | 273.46 | Zhao et al., | ||
| 24 | 418 | Kumaran and Hur, | ||
| 25 | 372 | Kumaran and Hur, | ||
| 26 27 | 334 | Kumaran and Hur, | ||
| 28 | 298 | Kumaran et al., | ||
| 30 | 79.6 | Gangadevi and Muthumary, | ||
| 31 | 211.1 | Gangadevi and Muthumary, | ||
| 32 | 800 | Zhang P. et al., | ||
| 33 | 846.1 | Liu K. et al., | ||
| 34 | 57.54 | Nithya and Muthumary, | ||
| 35 | 40 | Soliman et al., | ||
| 36 | 245 | Pandi et al., | ||
| 37 | 172.3 | Elavarasi et al., | ||
| 38 | 795 | Kumaran et al., | ||
| 39 | 157.38 | Merlin et al., | ||
| 40 | 77.23 | Rebecca et al., | ||
| 41 | 66 | Garyali et al., | ||
| 42 | 70–350 | Yang et al., | ||
| 43 | 550 | Elavarasi et al., | ||
| 44 | 152.26 | Hemamalini et al., | ||
| 45 | 14.7 | Somjaipeng et al., | ||
| 46 | 1215 | Zaiyou et al., | ||
| 47 | 334.92–1337.56 | Qiao et al., | ||
| 48 | 152.5 mg/Kg dry weight | Kasaei et al., |
List of podophyllotoxin producing endophytic fungi and their host plants.
| 1 | – | Chandra, | ||
| 2 | 0.5–189 | Eyberger et al., | ||
| 3 | 30 μg/g dry weight of mycelia | Puri et al., | ||
| 4 | 2.418 | Cao et al., | ||
| 5 | 28 μg/g dry weight of mycelia | Kour et al., | ||
| 6 | – | Zhao et al., | ||
| 7 | – | Zhao et al., | ||
| 8 | – | Zhao et al., | ||
| 9 | – | Zhao et al., | ||
| 10 | – | Zhao et al., | ||
| 11 | 29 μg/g dry weight of mycelia | Nadeem et al., | ||
| 12 | Chloroform extract: 50.5 mg; Butanol extract: 348 mg; Methanol extract of the mycelia: 1139.9 mg | Liang et al., | ||
| 13 | – | Wang et al., | ||
List of camptothecin, 9-methoxycamptothecin, 10-hydroxycamptothecin producing endophytic fungi, and their host plants.
| 1 | 18 μg/mg of the chloroform extract | Puri et al., | ||
| 2 | 49.6 | Amna et al., | ||
| 3 | – | Rehman et al., | ||
| 4 | – | Kusari et al., | ||
| 5 | 0.37 | Shweta et al., | ||
| 6 | 0.53 | |||
| 7 | 197.82 μg/L | Pu et al., | ||
| 8 | – | Ding et al., | ||
| 9 | 37 | Su et al., | ||
| 29 | ||||
| 24 | ||||
| 17 | ||||
| 10 | 40 μg/g | Ran et al., | ||
| 150 μg/L |
List of cytotoxic compounds isolated from endophytic fungi of terrestrial habitats.
| 1 | Phomoxanthone A | KB | 0.99 | Isaka et al., | ||
| Phomoxanthone B | KB | 4.1 | ||||
| 2 | Brefeldin A | KB | 0.18 | Chinworrungsee et al., | ||
| 8-Deoxy-trichothecin | KB | >62.81 | ||||
| Trichothecolone | KB | 12.90 | ||||
| 7α-Hydroxytrichodermol | KB | >75.10 | ||||
| 7α-Hydroxyscirpene | KB | 8.47 | ||||
| 3 | Alternariol | L5178Y | 1.7 | Aly et al., | ||
| 4 | Tauranin | NCI-H460 | 4.3 | Wijeratne et al., | ||
| 5 | Trichodermamide C | HCT116 | 0.68 | Davis et al., | ||
| 6 | Monomethylsulochrin | KB | 30.0 | Wang et al., | ||
| Rhizoctonic acid | KB | 20.0 | ||||
| Asperfumoid 3 | KB | 20.0 | ||||
| 3,5-Dichloro-p-anisic acid 6 | KB | 5.0 | ||||
| 7 | Spiropreussione A | A2780 | 2.4 | Chen et al., | ||
| 8 | Ent-4(15)-eudesmen-11-ol-1-one | NCI- H187 | 11 | Isaka et al., | ||
| 9 | Ergoflavin | ACHN | 1.2 | Deshmukh et al., | ||
| 10 | Cochliodinol | L5178Y | 7.0 | Debbab et al., | ||
| 11 | Pestaloficiol L | HeLa | 8.7 | (Liu L. et al., | ||
| 12 | Photinides A | MDA-MB-231 | 24.4 | Ding et al., | ||
| 13 | 6-O-Methylalteranin | L5178Y | 4.2 | Debbab et al., | ||
| 14 | Chaetomugilin A Chaetomugilin D | Brine shrimp | 78.3 | Qin et al., | ||
| 15 | Eremophilanolide 1 | KB | 3.8–21 | Isaka et al., | ||
| 16 | Oblongolides Z | KB | 37 | Bunyapaiboonsri et al., | ||
| 17 | Tree from Gassan stock farm | Allantopyrone A | HL60 | 0.32 | Shiono et al., | |
| 18 | Chaetoglobosins V | KB | 23.53 | Zhang J. et al., | ||
| Chaetoglobosins W | KB | 21.17 | ||||
| 19 | Massarigenin D | LO2 | 19.6 | Sun et al., | ||
| Spiromassaritone | LO2 | 7.2 | ||||
| Paecilospirone | LO2 | 12.4 | ||||
| 20 | Beauvericin | PC-3 | 49.5 | Wang et al., | ||
| 21 | Rohitukine | HCT-116 MCF7 | 10 | Mohana Kumara et al., | ||
| 22 | Annulosquamulin | MCF7 | 3.19 | Cheng et al., | ||
| (3S)-7-hydroxymellein | MCF7 | 2.78 | ||||
| 23 | Tenuissimasatin | HCT-8 | >1 | Fang et al., | ||
| (6aR, 6bS, 7S)-3, 6a, 7, 10-tetrahydroxy-4, 9-dioxo-4, 6a, 6b, 7, 8, 9-hexahydroperylene | HCT-8 | 1.78 | ||||
| 24 | Chaetoglobosin X | H22 | 3.125 | Wang et al., | ||
| 25 | Altersolanol | Angiogenesis assays | – | Pompeng et al., | ||
| 26 | Arisugacin B | HeLa | 24–60 | Sun et al., | ||
| 27 | Perenniporin A | HeLa | 30.44 | Wu et al., | ||
| 28 | Alternariol-10-methyl ether | HL-60 | 85 | Devari et al., | ||
| HeLa | >100 | |||||
| 29 | 2, 14-dihydrox-7-drimen-12, 11-olide | HepG2 | 61 | Mohamed et al., | ||
| 30 | Colchatetralene | THP-1 | 30 | Budhiraja et al., | ||
| 31 | Ginsenocin | MKN45 | 1.91 | Zheng et al., | ||
| Penicillic acid | MKN45 | 2.85 | ||||
| Brefeldin A | MKN45 | < 0.001 | ||||
| 32 | (R)-5-hydroxy-2-methylchroman-4-one | HL-60 | 4 | Zilla et al., | ||
| 33 | Oosporein | A549 | 21 | Alurappa et al., | ||
| 34 | Penifupyrone | KB | 4.7 | Chen et al., | ||
| 35 | Diglucotol | MCF7 | 97.56 | Wang et al., | ||
| Cerevisterol | MCF7 | 32.4 | ||||
| Ergosterol peroxide | MCF7 | 64.5 | ||||
| 36 | Pestalotin | HT-29 | 16.69 | Akay et al., | ||
| (S)-4-butoxy-6-((S)-1-hydroxypentyl)-5,6-dihydro-2H-pyran-2-one | HT-29 | 82.18 | ||||
| 37 | Phenochalasin B | SMMC-7721 | 7.43 | Lin et al., | ||
| [12]-cytochalasin | SMMC-7721 | 0.88 | ||||
| 38 | Taxol | HCT15 | 3.5 | Gokul Raj et al., | ||
| 39 | Eupenicinicol C | THP-1 | – | Li and Kusari, | ||
| 40 | 6,7- dehydropaxilline | MDA-MB-231 | >50 | Gao et al., | ||
| Spirotryprostatin F | MDA-MB-231 | 35.5 | ||||
| N-demethyl melearoride A | MDA-MB-231 | >50 |
Among the isolated compounds, only potent compounds are included in the column “isolated compound/s”.
Cell lines: OVCAR-3 (Ovarian cancer), Jurkat (Human T cell leukemia), Jurkat-JR16 (Jurkat cells overexpressing Bcl2), LOVO (Colon cancer), A549 (Lung cancer), MDA-MB-435 (Breast cancer), HepG2 (Liver cancer), HL-60 (Promyelocytic leukemia), KB (Oral cancer), KBv200 (Multidrug resistant cells), MCF7 (Breast cancer), Caco-2 (Colon cancer), PC-3 (Prostate cancer), HeLa (Cervical cancer), A431 (Skin cancer), MDA-MB-231 (Breast cancer), MIA PaCa-2 (Pancreatic cancer), T47D (Breast cancer), HT 29 (Colon cancer), HEK293 (Kidney), SMMC-7721 (Liver cancer), HCT 15 (Colon cancer), THP-1 (Acute monocytic leukemia), U2-OS (Bone cancer), L5178Y (Mouse lymphoma), HEp2 (Cervical cancer), PC-12 (Rat adrenal gland cancer), KV/MDR (Multi-drug resistant oral cancer), SW620 (Colon cancer), 95-D (Lung cancer), Kato-3 (Gastric cancer), CaSki (Cervical cancer), NCI-H460 (Lung cancer), SW1990 (Pancreatic cancer), DU145 (Prostate cancer), BC-1 (Lymphoma), Vero (African green monkey kidney fibroblasts), NCI-H187 (Lung cancer), SF-268 (Brain cancer), HCT 116 (Colon cancer), A2780 (Ovarian cancer), BEL-7404 (Liver cancer), ACHN (Kidney cancer), Panc-1 (Pancreatic cancer), Calu1 (Lung cancer), K562 (Chronic myelogenous leukemia), LO2 (Liver), HCT-8 (Colon cancer), H22 (Mouse liver cancer), U-87 (Brain cancer), BGC-823 (Gastric cancer), U251 (Brain cancer), A-2 (Lung cancer), PC-3M (Metastatic prostate cancer), MDCK (Dog kidney), OVCAR-5 (Ovarian cancer), CV1 (Kidney), MFC (Mouse gastric cancer), SK-OV-3 (Ovarian cancer), SK-MEL-2 (Skin cancer), XF-498 (Brain cancer), P388 (Mouse lymphoma), MKN45 (Gastric cancer), and U937 (Histiocytic lymphoma).
List of marine cytotoxic endophytic fungal metabolites.
| 1 | Seaweed | Kasanosin A | NT | – | Kimura et al., | |
| 2 | Apralactone A | 36 cancer cell lines | 0.28–>32.64 | Greve et al., | ||
| 3 | Epoxyphomalin A | 36 Human cancer cell lines | 0.017–11.42 | Mohamed et al., | ||
| 4 | Sterigmatocystin | A549 | 1.86 | Lee et al., | ||
| Averantin | A549 | 3.15 | ||||
| Methylaverantin | A549 | 0.64 | ||||
| Nidurufin | A549 | 1.83 | ||||
| 5 | 7-nor-ergosterolide | NCI-H460 SMMC-7721 SW1990 | 5 | Cui et al., | ||
| 3β,11α-dihydroxyergosta-8,24(28)-dien-7-one | NCI-H460 | NR | ||||
| 6 | Cytoglobosins A | A549 | >10 | Cui et al., | ||
| 7 | 11β-methoxycurvularin | K562 | 12.4 | Aly et al., | ||
| 11a-methoxycurvularin 4 | K562 | 41.1 | ||||
| Dehydrocurvularin 6 | K562 | 37.0 | ||||
| 1-chloro-2,4-dihydroxy-5-methoxy-7-methylanthraquinone | K562 | 24.8 |
Among the isolated compounds, only potent compounds are included in the column “isolated compound/s”.
NA, Not active; NR, Not reported; NT, Not tested.
List of anticancer compounds isolated from endophytic fungi from mangrove habitats.
| 1 | 2-(7′-hydroxyoxooctyl)-3-hydroxy-5-methoxybenzeneacetic acid ethyl ester | HEp2 | 25 | Huang et al., | ||
| 2 | Cytosporones J-N Pestalasins A-E Pestalotiopsoid A | L5178Y | Not Active up to 10 μg/mL | Xu et al., | ||
| 3 | Pestalotiopsone A Pestalotiopsone B Pestalotiopsone C Pestalotiopsone D Pestalotiopsone E Pestalotiopsone F | L5178Y | NA | Xu et al., | ||
| 4 | Secalonic acid D | HL60 | 0.38 | Zhang J. Y. et al., | ||
| 5 | Phomopsis-H76 A Phomopsis-H76 B Phomopsis-H76 C | KB | All the compounds are inactive against all the tested cell lines | Yang et al., | ||
| 6 | Kandelia woody tissue | 1-hydroxy-3-methyl anthracene-9,10-dione | KB | 3.17 | Zhang J. Y. et al., | |
| 7 | Zh6-B1 (unidentified) | 3R,5R-Sonnerlactone 3R,5S-Sonnerlactone | KV/MDR | 42.4 | Li et al., | |
| 8 | XG8D (unidentified) | Merulin A | BT474 | 4.98 | Chokpaiboon et al., | |
| Merulin B | BT474 | >10 | ||||
| Merulin C | BT474 | 1.57 | ||||
| 9 | Penicinoline | 95-D | 0.57 | Shao et al., | ||
| 10 | Unidentified mangrove (Taiwan Strait) | Paeciloxocins A Paeciloxocins B | HepG2 | 1 | Wen et al., | |
| 11 | Expansols A | A549 | NR | Lu et al., | ||
| Expansols B | A549 | 1.9 | ||||
| 12 | 5-O-methyl-2′-methoxy-3′-methylalpinumisoflavone | HEp2 | 4 | Huang et al., | ||
| 13 | Alterporriol K | MDA-MB-435 | 26.97 | Huang et al., | ||
| Alterporriol L | MDA-MB-435 | 13.11 | ||||
| Alterporriol M | MDA-MB-435 | NT | ||||
| 14 | Ethyl acetate extract was used for cytotoxic studies. Tetradecane was isolated from the extract. | HEp2 | 125 | Bhimba et al., | ||
| 15 | Taxol | NT | NT | Elavarasi et al., | ||
| 16 | Rhytidchromones A | MCF7 | 19.3 | Chokpaiboon et al., | ||
| Rhytidchromones B | MCF7 | >25 | ||||
| Rhytidchromones C | MCF7 | >25 | ||||
| Rhytidchromones D | MCF7 | >25 | ||||
| Rhytidchromones E | MCF7 | 17.7 |
Among the isolated compounds, only potent compounds are included in the column “isolated compound/s”.
NA, Not active; NR, Not reported; NT, Not tested.